People
All our partners are very experienced in their respective expertise areas and collectively bring an unparalleled capability to bear on Client problems of expertise and/or capacity. TranScrip Partners will continue to grow its expert base as new Senior Partners and Partners join.
The current line-up of Senior Partners include:
| Senior Partners | Competencies & Expert area |
| Richard Bax, Senior Partner | Drug development of anti-infectives, including antibiotics, antivirals, antifungals and vaccines |
| Chris Blakeley, Senior Partner | Drug development across several therapeutic areas, especially oncology, urology and respiratory |
| Paul Branthwaite, Senior Partner | Business development and marketing |
| Carol Burley, Partner | Clinical development, project management, medical writing |
| Sarah Daniels, Senior Partner | Pharmacovigilance (EU QPPV), drug development and medical affairs in virology, oncology and CNS |
| Flic Gabbay, Senior Partner | Drug development, several therapeutic areas especially anti-infectives, respiratory. Pre-registration pharmacovigilance and Special interest in Education |
| David Goldsmith, Senior Partner | Academic advisor in nephrology, transplantation and toxicology |
| Colin Knight, Partner | Pharmacovigilance, medical information, medical writing |
| Marcin Mankowski, Senior Partner | Drug development and medical affairs, especially in anti-infectives, including antibiotics, antifungals and antivirals |
| Ursula Mason, Senior Partner | Drug discovery, development programme design & leadership, CNS & immuno-inflammatory diseases. Biotechnology products |
| Craig McCarthy, Senior Partner | Regulatory affairs across different therapeutic areas |
| Alex Meldrum, Partner | Regulatory affairs across different therapeutic areas |
| Karol Sikora, Senior Partner | Academic advisor in oncology |
| N Sreeharan, Senior Partner | Drug development and medical affairs in multiple therapeutic areas. Special interest in Governance and Education |
